Last Updated：2025/11/27
The prescriptibility of the new medication was debated at the panel, as regulators weighed potential benefits against risks.
See correct answer
The prescriptibility of the new medication was debated at the panel, as regulators weighed potential benefits against risks.
音声機能が動作しない場合はこちらをご確認ください
Edit Histories（0）
